Lung Cancer Therapies Market 2018-2024
07-Jun-2018 | Number of pages: 193 | Report Id: BMRC PH 121 | Report Format: | Status: Published

Premium Insight Global Lung Cancer Therapies Market 2018-2024

Brandessence Market Research is working on a new report titleGlobal Lung Cancer Therapies Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2018-2024″.Rising incidences of lung cancer due to increasingnumber of smokers and increasing pollution due to rapid industrialization are major key factor which drives the Immunotherapy Drug Market.

Global Lung Cancer Therapies Market Reports –

Lung cancer is the uncontrolled growth of abnormal cells that develop in one or both lungs generally in the cells whichpassages the air. The abnormal cells do not develop into healthy lung tissue. They divide rapidly and develop the tumors.Mostlysmokingthe cigarette causes lung cancers.As tumors become bigger in size and more numerous then lung’s ability to provide the bloodstream with oxygen is decreased.Primary lung cancer develops in the lungs and secondary lung cancer starts some other parts of the body, metastasizes, and reaches the lungs. There are different types of cancers and treatment for this is also varies from type to type.Cigarette smoke contains at least 73 known carcinogens.More cigarettes smoking rate per day and the earlier starting of smoking will have greater risk of lung cancer. The Symptoms of Primary Lung Cancer are Coughing, Shortness of breath, Coughing up blood,repeated problems with pneumonia or bronchitis and Swelling of the neck face. The Symptoms of Primary Lung Cancer are Fatigue, Loss of appetite or weight loss, Headache, Bone & joint pain, Bone fractures not related to accidental injury and General weakness.

Pathologist identifieslung cancer by using a physical exam, imaging technique and by lab tests. Lung Cancer treatment depends on the type, stage, and how progressive it is. Treatments include surgery, chemotherapy, radiation therapy, and targeted therapy. If lung cancer is suspected as a result of a screening procedure (CT, MRI or PET scan), a small piece of tissue from the lung must be examined under a microscope to look for cancer cells called a biopsy.Recently, the FDA approved the first liquid biopsy for lung cancer which utilizes free floating DNA in the bloodstream for analysis.If cancer cells are found in the tissue sample, a genetic test may be performed. Genetic testing also referred as “molecular profiling or mutation profiling”.There are two major types of lung cancer, Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC).Drugs Approved for Non-Small Cell Lung Cancer are Abitrexate, Abraxane, Afatinib Dimaleate Afinitor, Alecensa, Bevacizumab, Brigatinib, Carboplatin, Docetaxel,  Erlotinib Hydrochloride,Gilotrif, Iressa, Mustargen, Osimertinib Paclitaxel, Paraplatin, Tarceva, Taxol Taxotere, Tecentriq, Trametinib, Trexall, Vinorelbine Tartrate, Xalkori and Zykadia.

Drugs Approved for Small Cell Lung Cancer are Abitrexate,Afinitor, Doxorubicin Hydrochloride Etopophos, Etoposide, Etoposide Phosphate, Everolimus, Folex, Hycamtin,Mechlorethamine Hydrochloride, Methotrexate, Mexate,Mustargen, Topotecan Hydrochlorideand Trexall.

Global Lung Cancer Therapies Market is segmented on the basis of Types, End user, Treatment and Geography. Based upon Types,Global Lung Cancer Therapies Market is classified as Push button Lung Cancer, Pressure activated Lung Cancer and Side button Lung Cancer and Others. On the basis of End users Global Lung Cancer Therapies Market is classified into Hospitals, Clinics, Diagnostics centers,Pathology laboratories, Home diagnostics andothers. On the basis of treatment Global lung Cancer Therapies Market is classified into Surgery, Chemotherapy, Radiotherapy, Photodynamic therapy (PDT) and Laser therapy.

The regions covered in Global Lung Cancer Therapies Marketreport are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, Global Melanoma Drug Market sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players for Global Lung Cancer Therapies Market Reports –

Global Lung Cancer Therapies Market reports cover prominent players likeF. Hoffmann-La Roche AG,Bayer, Novartis, PfizerInc., Merck & Co. Inc., Bristol-Myers Squibb, Eli Lilly and Company, Sanofi, Celgene, AstraZeneca,Ventana, Roche, Genentech, Glaxosmith, Agennix AG, Novartis AG, Boehringer Ingelheim, Takeda Pharmaceuticals Co. Ltd, Ariad Pharmaceuticals, Johnson and Johnson, Abbvie Inc.,VisionGate Inc., Asterias Biotherapeutics, Daiichi Sankyo, Teva Pharmaceuticals and others.

 Global Lung Cancer Therapies Market Dynamics –

Rising incidences of lung cancer due to increasing smoking population are major key factors that drive the growth of Global Lung Cancer Therapies Market. The risk of lung cancer is ten timesmore in smokers as compared to non-smokers. Also, launch of premium priced drugs, new innovative radiation therapies like Radiation, Chemotherapy coupled with rising incidences of Non-Small Cell Lung Cancer(NSCLC)are the major driving factors for the Global Lung Cancer Therapies Market. However, generalization of the major drugs might restrict the growth of Global Lung Cancer Therapies Market. Also poor cancer diagnostic facilities in many countries and the adverse effects of chemotherapies like Nausea, vomiting, Diarrhea, Fatigue and Mouth sores are the factors that are likely to restrain the Global Lung Cancer Therapies Market. But the arrival of Nanomedicine to treat lung cancer like Abraxane and the growing approvals in the lung cancer therapeutics market boost the opportunities for the rise in the Lung Cancer Therapies Market.

 Global Lung Cancer Therapies Market Regional Analysis –

North America is having highest market sharefor Global Lung Cancer Therapies Market in the near future, due to wide advancements in thetechnology. The highest demand in the region was continued by factors which include increasing occurrences of lung cancer and rising levels of geriatric population. Also, the change in lifestyles with high smoking habits which causesa large pool of lung cancer population is also responsible for the huge incidences of lung cancer in North America.

Europe is the second largest market for Global Lung Cancer Therapies Market due to the increased government expenditure in the field of research and development of novel drugs. The Global Lung Cancer Therapies Market in Asia Pacific is valued to expand at high speed during the forecast period. In terms of revenue, the Global Lung Cancer Therapies Market in China and India is likely to grow significantly due to increase in population, development of economies, rise in prevalence of unhealthy lifestyle, and surge in air pollution.Furthermore, increase in awareness of disease and government initiatives for improving health care facilities are expected to boost the regional market to a certain extent.

 Key Benefits for Global Lung Cancer Therapies Market Reports –

  • Global Lung Cancer Therapies Market report covers in depth historical and forecast analysis.
  • Global Lung Cancer Therapies Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Global market sale (K Units), Global market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
  • Global Lung Cancer Therapies Market report helps to identify opportunities in market place.
  • Global Lung Cancer Therapies Market report covers extensive analysis of emerging trends and competitive landscape.

Global Lung Cancer Therapies Market Segmentation

 Global Lung Cancer Therapies Market: By Types Analysis

  • Push button Lung Cancer
  • Pressure activated Lung Cancer
  • Side button Lung Cancer
  • Others

Global Lung Cancer Therapies Market: By End Users Analysis

  • Hospitals
  • Clinics
  • Diagnostics centers
  • Pathology laboratories
  • Home diagnostics
  • Others

Global Lung Cancer Therapies Market: By Treatment Analysis

  • Surgery
  • Chemotherapy
  • Radiotherapy
  • Photodynamic therapy (PDT)
  • Laser therapy
  • Others

Global Lung Cancer Therapies Market: By Regional & Country Analysis

  • North America
    • U.S.
    • Mexico
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America
    • Brazil
  • The Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Global Lung Cancer Therapies Market 2018-2024

Our 193 pages report provides 68 tables, 70 charts and graphs. The report covers historical and forecast data of North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Our study focuses on the most lucrative areas in the industry and the future market prospects. Market covers financial results, trends, opportunities and revenue predictions from 2018 to 2024. Significant rise in research and development activities by leading vendors.

Why you should buy this report:

  • To receive a comprehensive analysis of the prospects for Global Lung Cancer Therapies Market
  • To receive forecasts of Global Lung Cancer Therapies Market Sales in leading country markets from 2018-2024, including leading and emerging country from developed and developing regions
  • To discover the views of experts in the Global Lung Cancer Therapies Market sector
  • To determine the forces and factor that influences the market for Global Lung Cancer Therapies Market: drivers, restraints, opportunities and threats
  • To find out where theGlobal Lung Cancer Therapies Market is heading – both technologically and commercially from 2018-2024
  • Report Include tables of contract/projects and its value and description by  region and Country

Global Lung Cancer Therapies Market: By Region Analysis

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Global XX XX XX XX XX
North America XX XX XX XX XX
Europe XX XX XX XX XX
Asia Pacific XX XX XX XX XX
Latin America XX XX XX XX XX
Middle East & Africa XX XX XX XX XX
Global XX XX XX XX XX

Source: Brandessence Market Research, 2018

Global Lung Cancer Therapies Market: By Type Analysis

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Push Button Lung Cancer XX XX XX XX XX
Pressure Activated Lung Cancer XX XX XX XX XX
Side Button Lung Cancer XX XX XX XX XX
Others XX XX XX XX XX

Source: Brandessence Market Research, 2018

Global Lung Cancer Therapies Market: By End UserAnalysis

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Hospitals XX XX XX XX XX
Clinics XX XX XX XX XX
Diagnostics Centres XX XX XX XX XX
Pathology Laboratories XX XX XX XX XX
Home Diagnostics XX XX XX XX XX
Others XX XX XX XX XX

Source: Brandessence Market Research, 2018

Global Lung Cancer Therapies Market: By Treatment Analysis

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Surgery XX XX XX XX XX
Chemotherapy XX XX XX XX XX
Radiotherapy XX XX XX XX XX
Photodynamic Therapy XX XX XX XX XX
Laser Therapy XX XX XX XX XX
Others XX XX XX XX XX

Source: Brandessence Market Research, 2018

Why You Must Buy This Report:

  • This report features news, insights, the latest developments and an in depth survey ofGlobal Lung Cancer Therapies Market with up-to-date analysis as well as tables, graphs and charts. This report is a vital addition to gaining an understanding of this market sector and will give your company ‘the edge’ on your competitors.

Email me today to order this report or to ask for assistance. I look forward to receiving your email on sales@brandessenceresearch.com

Companies Mentioned in This Report,

  • F. Hoffmann-La Roche AG
  • Bayer
  • Novartis
  • Pfizer Inc.
  • Merck & Co. Inc.
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • Sanofi
  • Celgene
  • AstraZeneca
  • Ventana
  • Roche
  • Genentech
  • Glaxosmith
  • Agennix AG
  • Novartis AG
  • Boehringer Ingelheim
  • Takeda Pharmaceuticals Co. Ltd
  • Ariad Pharmaceuticals
  • Johnson and Johnson
  • Abbvie Inc.
  • VisionGate Inc.
  • Asterias Biotherapeutics
  • Daiichi Sankyo
  • Teva Pharmaceuticals
  • Others

 

Table of Content

  1. Chapter – Report Methodology
    • Research Process
    • Primary Research
    • Secondary Research
    • Market Size Estimates
    • Data Triangulation
    • Forecast Model
    • USP’s of Report
    • Report Description
  2. Chapter – Global Lung Cancer Therapies Market Overview: Qualitative Analysis
    • Market Introduction
    • Executive Summary
    • Global Porcine Vaccine Market Classification
    • Market Drivers
    • Market Restraints
    • Market Opportunity
    • Global Lung Cancer Therapies Market: Trends
    • Porter’s Five Forces Analysis
      • Bargaining Power of Suppliers
      • Bargaining Power of Consumers
      • Threat of New Entrants
      • Threat of Substitute Product and Services
      • Competitive Rivalry within the Industry
    • Market Attractiveness Analysis
      • Market Attractiveness Analysis by Segmentation
      • Market Attractiveness Analysis by Region
  1. Chapter – Global Lung Cancer Therapies Market Overview: Quantitative Analysis
    • Global Lung Cancer Therapies Market Production (K Unit), Market Share (%) and Growth Rate (%), 2014- 2024
    • Global Lung Cancer Therapies Market Consumption (K Unit), Market Share ( %) and Growth Rate, 2014- 2024
    • Global Lung Cancer Therapies MarketRevenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2024
  2. Chapter – Global Lung Cancer Therapies Market: by Type Indication
  3. Chapter – Global Lung Cancer Therapies Market: by End User
  4. Chapter – Global Lung Cancer Therapies Market: by Treatment
    • Global Lung Cancer Therapies Market (USD Million), by Manufacturer, 2014 – 2024
    • Global Lung Cancer Therapies Market Production (K Unit), by Manufacturer, 2014 – 2024
    • Global Lung Cancer Therapies Market Consumption (K Unit), Manufacturer, 2014 – 2024
    • Global Lung Cancer Therapies Market Share (%), by Manufacturer, 2017
    • Global Lung Cancer Therapies Market Price (USD/Unit), by Manufacturer, 2014 – 2024
    • Global Lung Cancer Therapies Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2024
    • Merger & Acquisition
    • Collaborations and Partnership
    • New Product Launch
  5. Chapter – Global Lung Cancer Therapies Market: Regional Analysis
    • North America
    • North America Global Lung Cancer Therapies Market Revenue (USD Million) and Growth Rate (%), 2014 – 2024.
    • North America Global Lung Cancer Therapies Market Revenue (USD Million) By Country, 2014 – 2024.
    • North America Global Lung Cancer Therapies Market Revenue Market Share (%) By Country, 2014 – 2024.
    • North America Global Lung Cancer Therapies Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    • North America Global Lung Cancer Therapies Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    • North America Global Lung Cancer Therapies Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  6. Chapter – Company Profiles
    • Bayer AG.
      • Overview
      • Financials
      • Product portfolio
      • Global Lung Cancer Therapies Market Revenue (USD Million), Production (K Unit), Consumption (K Unit) and Market Share (%), 2014 – 2017
      • Global Lung Cancer TherapiesMarket Share (%), 2014 – 2017
      • Business strategy
      • Recent developments
    • Hoffmann-La Roche AG
    • Bayer
    • Novartis
    • Pfizer Inc.
    • Merck & Co. Inc.
    • Bristol-Myers Squibb
    • Eli Lilly and Company
    • Sanofi
    • Celgene
    • AstraZeneca
    • Ventana
    • Roche
    • Genentech
    • Glaxosmith
    • Agennix AG
    • Novartis AG
    • Boehringer Ingelheim
    • Takeda Pharmaceuticals Co. Ltd
    • Ariad Pharmaceuticals
    • Johnson and Johnson
    • Abbvie Inc.
    • VisionGate Inc.
    • Asterias Biotherapeutics
    • Daiichi Sankyo
    • Teva Pharmaceuticals
    • Others

 

  1. Chapter – Market Research and Findings

 

  • F. Hoffmann-La Roche AG
  • Bayer
  • Novartis
  • Pfizer Inc.
  • Merck & Co. Inc.
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • Sanofi
  • Celgene
  • AstraZeneca
  • Ventana
  • Roche
  • Genentech
  • Glaxosmith
  • Agennix AG
  • Novartis AG
  • Boehringer Ingelheim
  • Takeda Pharmaceuticals Co. Ltd
  • Ariad Pharmaceuticals
  • Johnson and Johnson
  • Abbvie Inc.
  • VisionGate Inc.
  • Asterias Biotherapeutics
  • Daiichi Sankyo
  • Teva Pharmaceuticals
  • Others